Keyphrases
Myogenic Progenitors
95%
Induced Pluripotent Stem Cells (iPSCs)
83%
Stem Cell-derived
64%
Pluripotent Stem Cells
49%
Myotubes
43%
Autologous Cell Therapy
40%
Gene Correction
40%
Blood Outgrowth Endothelial Cells
40%
Muscular Dystrophy
40%
Transplantation
34%
Cell-based
33%
Pax7
29%
Nonhuman Primate
27%
Dystrophic Mice
27%
Duchenne muscular Dystrophy
27%
Cas9 Protein
23%
Myofiber
20%
Satellite Cells
20%
Universal Genetic Code
20%
Fukutin-related Protein
20%
Patient-specific iPSCs
20%
Correction Strategy
20%
Genomic Safe Harbor
20%
Dystroglycanopathy
20%
Childhood Stroke
20%
Pro-inflammatory Phenotype
20%
LAMC1
20%
Early Coronary Atherosclerosis
20%
Sickle Cell Anemia
20%
Human Pluripotent Stem Cells (hPSCs)
20%
High Mobility Group Box 1 (HMGB1)
20%
CAPN3
20%
Small Molecules
20%
Gene Expression
20%
Kruppel-like Factor 2 (KLF2)
20%
Limb-girdle muscular Dystrophy
20%
RelA
20%
Muscle Graft
20%
Human iPSC
20%
Exon 44
20%
Patient-specific
20%
Cyclic GMP
20%
Quality Safety
20%
Donor-derived
16%
Long-term Engraftment
16%
Pluripotent
16%
Mouse Model
13%
Heritable Risk
13%
Tissue Stem Cells
13%
Fiber Cells
13%
Biochemistry, Genetics and Molecular Biology
Induced Pluripotent Stem Cell
100%
Stem Cell
83%
Maturation
40%
PAX7
35%
Skeletal Muscle
30%
CRISPR/Cas9
27%
Dystroglycanopathy
20%
Small Molecule
20%
Gene Expression
20%
Immune Response
20%
Fukutin-Related Protein
20%
Calpain-3
20%
Exon
20%
Genomics
20%
Mouse Model
17%
High-Mobility Group
15%
Biodistribution
15%
Wild Type
14%
NOD SCID Gamma Mouse
14%
Stem Cell Transplantation
12%
Lentivirus Vector
12%
Macaca fascicularis
10%
Mesoderm
10%
Primate Model
10%
Gene Expression Profiling
10%
Paraxial Mesoderm
10%
Bulk RNA Sequencing
10%
Human Induced Pluripotent Stem Cell
10%
Clinical Trial
10%
Muscle Regeneration
9%
Glycosylation
8%
Transgene
8%
Cell Transplantation
8%
Stem Cell Line
8%
Genome Editing
7%
Gene Knockin
7%
Genetics
5%
Quality Control
5%
Isoform
5%
Disease Modeling
5%
Normal Human
5%
Focal Adhesion
5%
Upregulation
5%
Heavy Meromyosin
5%
Gene Linkage
5%
Laminin
5%
Lipopolysaccharide
5%
Differentially Expressed Gene
5%
Chromatin Accessibility
5%
Transcriptome
5%
